BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 11434451)

  • 1. Strategies for the treatment of cancer pain in the new millennium.
    Ripamonti C; Dickerson ED
    Drugs; 2001; 61(7):955-77. PubMed ID: 11434451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methadone for cancer pain: what have we learned from clinical studies?
    Soares LG
    Am J Hosp Palliat Care; 2005; 22(3):223-7. PubMed ID: 15909785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphine to methadone conversion: an interpretation of published data.
    Pollock AB; Tegeler ML; Morgan V; Baumrucker SJ
    Am J Hosp Palliat Care; 2011 Mar; 28(2):135-40. PubMed ID: 20555039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid switch to oral methadone in cancer pain.
    Mancini I; Lossignol DA; Body JJ
    Curr Opin Oncol; 2000 Jul; 12(4):308-13. PubMed ID: 10888415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of methadone in opioid rotation-a Polish experience.
    Leppert W
    Support Care Cancer; 2009 May; 17(5):607-12. PubMed ID: 19043743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric palliative care: use of opioids for the management of pain.
    Zernikow B; Michel E; Craig F; Anderson BJ
    Paediatr Drugs; 2009; 11(2):129-51. PubMed ID: 19301934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of opioid tolerance -- molecular mechanisms and clinical consequences].
    Freye E; Latasch L
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Jan; 38(1):14-26. PubMed ID: 12522725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphine versus methadone in the pain treatment of advanced-cancer patients followed up at home.
    Mercadante S; Casuccio A; Agnello A; Serretta R; Calderone L; Barresi L
    J Clin Oncol; 1998 Nov; 16(11):3656-61. PubMed ID: 9817288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous ketamine infusion as an adjuvant to morphine in a 2-year-old with severe cancer pain from metastatic neuroblastoma.
    Tsui BC; Davies D; Desai S; Malherbe S
    J Pediatr Hematol Oncol; 2004 Oct; 26(10):678-80. PubMed ID: 15454842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study.
    Mercadante S; Casuccio A; Fulfaro F; Groff L; Boffi R; Villari P; Gebbia V; Ripamonti C
    J Clin Oncol; 2001 Jun; 19(11):2898-904. PubMed ID: 11387363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid and adjuvant analgesics: compared and contrasted.
    Khan MI; Walsh D; Brito-Dellan N
    Am J Hosp Palliat Care; 2011 Aug; 28(5):378-83. PubMed ID: 21622486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to switch from morphine or oxycodone to methadone in cancer patients? a randomised clinical phase II trial.
    Moksnes K; Dale O; Rosland JH; Paulsen O; Klepstad P; Kaasa S
    Eur J Cancer; 2011 Nov; 47(16):2463-70. PubMed ID: 21775131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphine-methadone opioid rotation in cancer patients: analysis of dose ratio predicting factors.
    Benítez-Rosario MA; Salinas-Martín A; Aguirre-Jaime A; Pérez-Méndez L; Feria M
    J Pain Symptom Manage; 2009 Jun; 37(6):1061-8. PubMed ID: 19171458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum concentrations of opioids when comparing two switching strategies to methadone for cancer pain.
    Moksnes K; Kaasa S; Paulsen Ø; Rosland JH; Spigset O; Dale O
    Eur J Clin Pharmacol; 2012 Aug; 68(8):1147-56. PubMed ID: 22374345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphine and alternative opioids in cancer pain: the EAPC recommendations.
    Hanks GW; Conno F; Cherny N; Hanna M; Kalso E; McQuay HJ; Mercadante S; Meynadier J; Poulain P; Ripamonti C; Radbruch L; Casas JR; Sawe J; Twycross RG; Ventafridda V;
    Br J Cancer; 2001 Mar; 84(5):587-93. PubMed ID: 11237376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of pain in oncology].
    De Conno F; Polastri D
    Tumori; 1997; 83(2 Suppl):S20-4. PubMed ID: 9235725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio?
    Ripamonti C; Groff L; Brunelli C; Polastri D; Stavrakis A; De Conno F
    J Clin Oncol; 1998 Oct; 16(10):3216-21. PubMed ID: 9779694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
    Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
    Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.